AI-generated summary
The authors pooled 20 studies of repeated low-level red light therapy in children with myopia. They report that, compared with controls, the treated group had slower axial elongation, less progression of refraction and greater subfoveal choroidal thickening over 6 to 24 months. The authors also note that a causal link to retinal damage has been suggested and needs further study.
- Participants
- 2,638
- Studies included
- 20
- Who or what was studied
- Chinese children aged 3 to 16 years with baseline spherical equivalent refraction between +0.75 and -10.00 diopters
- Limits stated in the abstract
- The abstract notes heterogeneity linked to baseline refraction and treatment frequency, and a suggested causal relationship between retinal damage and the treatment that requires further investigation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Purpose
This study aimed to evaluate the effects of repeated low-level red light (RLRL) therapy in intervening in the progression of myopia in children.
Methods
We searched PubMed, the Cochrane Library, Embase, Web of Science, and CNKI databases for relevant studies published from the inception of the databases to 30 April 2025. Subsequently, studies were screened according to the inclusion and exclusion criteria, and basic information and outcome data of the included studies were recorded. The risk of bias in randomized controlled trials (RCTs) and cohort studies was assessed using the RoB 2.0 tool and the NOS, respectively. Finally, meta-analysis was performed using RevMan 5.4, and meta-regression, sensitivity analysis, and publication bias assessment were conducted using STATA 17.
Results
A total of 20 studies were included in this study, involving 2,638 Chinese children, aged from 3 to 16 years, with a baseline spherical equivalent refraction (SER) ranging between +0.75 and -10.00 diopters. A meta-analysis showed that, compared with the control group, the RLRL group had a slower axial elongation, a lower progression of SER, and a greater increase in subfoveal choroidal thickness (SFCT). The changes in axial length (AL) at the 6th, 12th, and 24th months of follow-up in the RLRL group relative to the control group were -0.22 mm (95% CI: -0.25, -0.18; p < 0.00001), -0.30 mm (95% CI: -0.36, -0.24; p < 0.00001), and -0.61 mm (95% CI: -0.71, -0.52; p < 0.00001), respectively. The corresponding changes in SER at these time points were 0.40 D (95% CI: 0.31, 0.50; p < 0.00001), 0.61 D (95% CI: 0.47, 0.76; p < 0.00001), and 1.33 D (95% CI: 0.62, 2.03; p = 0.0002). Additionally, the changes in SFCT at the 6th and 12th months of follow-up were 31.21 μm (95% CI: 22.03, 40.38; p < 0.00001) and 29.72 μm (95% CI: 19.53, 39.92; p < 0.00001), respectively. Meta-regression and subgroup analysis revealed that the baseline SER and treatment frequency primarily contributed to the heterogeneity observed in this study.
Conclusion
This meta-analysis confirmed that RLRL therapy can effectively delay the progression of myopia in children during a 6-24 months follow-up, and the efficacy appears to be directly related to the degree of the baseline myopia and the LRLR treatment frequency. However, a causal relationship has been suggested between retinal damage and LRLR treatments, which requires further investigations. SYSTEMATIC REVIEW
Registration
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420251018947.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Meta-analysis, Myopia, Systematic review, Red light therapy, Control group, Publication bias, Heterogeneity. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.